262 related articles for article (PubMed ID: 37478159)
21. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
[TBL] [Abstract][Full Text] [Related]
22. Biochemical changes of macrophages and U87MG cells occurring as a result of the exposure to iron oxide nanoparticles detected with the Raman microspectroscopy.
Janik-Olchawa N; Drozdz A; Wajda A; Sitarz M; Planeta K; Setkowicz Z; Ryszawy D; Kmita A; Chwiej J
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 278():121337. PubMed ID: 35537264
[TBL] [Abstract][Full Text] [Related]
23. Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages.
Liu L; Sha R; Yang L; Zhao X; Zhu Y; Gao J; Zhang Y; Wen LP
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41197-41206. PubMed ID: 30398340
[TBL] [Abstract][Full Text] [Related]
24. Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages.
Escamilla-Rivera V; Uribe-Ramírez M; González-Pozos S; Lozano O; Lucas S; De Vizcaya-Ruiz A
Toxicol Lett; 2016 Jan; 240(1):172-84. PubMed ID: 26518974
[TBL] [Abstract][Full Text] [Related]
25. Iron oxide nanoparticles oxidize transformed RAW 264.7 macrophages into foam cells: Impact of pulmonary surfactant component dipalmitoylphosphatidylcholine.
Li H; Tao X; Song E; Song Y
Chemosphere; 2022 Aug; 300():134617. PubMed ID: 35430205
[TBL] [Abstract][Full Text] [Related]
26. DMSA-coated cubic iron oxide nanoparticles as potential therapeutic agents.
Çitoğlu S; Coşkun ÖD; Tung LD; Onur MA; Thanh NTK
Nanomedicine (Lond); 2021 May; 16(11):925-941. PubMed ID: 34015971
[No Abstract] [Full Text] [Related]
27. Iron oxide nanoparticles served as the primary carrier to increase drug loading in macrophages.
Zhao K; Ruan L; Liu X; Wu L; Cao J; Shen S
Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36541487
[TBL] [Abstract][Full Text] [Related]
28. Mutagenic Effects of Iron Oxide Nanoparticles on Biological Cells.
Dissanayake NM; Current KM; Obare SO
Int J Mol Sci; 2015 Sep; 16(10):23482-516. PubMed ID: 26437397
[TBL] [Abstract][Full Text] [Related]
29. Multi-Modal Visualization of Uptake and Distribution of Iron Oxide Nanoparticles in Macrophages, Cancer Cells, and Xenograft Models.
Liu Q; Huang J; Feng Q; Zhang T; Chen X; Li X; Liu X; Li H; Zhong Z; Xiao K
J Biomed Nanotechnol; 2019 Aug; 15(8):1801-1811. PubMed ID: 31219008
[TBL] [Abstract][Full Text] [Related]
30. Macrophage functionality and homeostasis in response to oligoethyleneglycol-coated IONPs: Impact of a dendritic architecture.
Casset A; Jouhannaud J; Garofalo A; Spiegelhalter C; Nguyen DV; Felder-Flesch D; Pourroy G; Pons F
Int J Pharm; 2019 Feb; 556():287-300. PubMed ID: 30557682
[TBL] [Abstract][Full Text] [Related]
31. Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model.
Ivask A; Pilkington EH; Blin T; Käkinen A; Vija H; Visnapuu M; Quinn JF; Whittaker MR; Qiao R; Davis TP; Ke PC; Voelcker NH
Biomater Sci; 2018 Jan; 6(2):314-323. PubMed ID: 29239410
[TBL] [Abstract][Full Text] [Related]
32. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
33. Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study.
Mabrouk M; Ibrahim Fouad G; El-Sayed SAM; Rizk MZ; Beherei HH
Biol Trace Elem Res; 2022 Aug; 200(8):3638-3665. PubMed ID: 34704196
[TBL] [Abstract][Full Text] [Related]
34. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings.
Feng Q; Liu Y; Huang J; Chen K; Huang J; Xiao K
Sci Rep; 2018 Feb; 8(1):2082. PubMed ID: 29391477
[TBL] [Abstract][Full Text] [Related]
35. Influence of Coating and Size of Magnetic Nanoparticles on Cellular Uptake for In Vitro MRI.
Cortés-Llanos B; Ocampo SM; de la Cueva L; Calvo GF; Belmonte-Beitia J; Pérez L; Salas G; Ayuso-Sacido Á
Nanomaterials (Basel); 2021 Oct; 11(11):. PubMed ID: 34835651
[TBL] [Abstract][Full Text] [Related]
36. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
Mao Z; Li X; Wang P; Yan H
Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
[TBL] [Abstract][Full Text] [Related]
37. Plasma Proteome Association and Catalytic Activity of Stealth Polymer-Grafted Iron Oxide Nanoparticles.
Wang M; Siddiqui G; Gustafsson OJR; Käkinen A; Javed I; Voelcker NH; Creek DJ; Ke PC; Davis TP
Small; 2017 Sep; 13(36):. PubMed ID: 28783260
[TBL] [Abstract][Full Text] [Related]
38. Iron oxide nanoparticles/nanocomposites derived from steel and iron wastes for water treatment: A review.
Jjagwe J; Olupot PW; Carrara S
J Environ Manage; 2023 Oct; 343():118236. PubMed ID: 37235992
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and interfacing of biocompatible iron oxide nanoparticles through the ferroxidase activity of Helicobacter Pylori ferritin.
Lee IL; Li PS; Yu WL; Shen HH
Biofabrication; 2012 Dec; 4(4):045001. PubMed ID: 23013844
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
